The top lawyer at Novartis (NVS) is stepping down as part of the fallout from the scandal over payments made by the drug maker to President Trump’s personal attorney. Felix Ehrat, 61, who was general counsel and a member of the Novartis executive committee since 2011, is retiring and will be succeeded by the chief risk and compliance officer, according to a statement released in conjunction with an investor meeting.

His departure follows the disclosure last week that Novartis paid $1.2 million in monthly installments to Michael Cohen’s Essential Consultants for access to the new Trump administration, as part of a one-year contract signed in February 2017. Cohen approached former Novartis chief executive Joe Jimenez, who authorized the deal, even though Cohen is not a registered lobbyist or an expert in health care matters.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy